Login / Signup

Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance.

Soie KwonJin Seong HyeonYoungae JungLilin LiJung Nam AnYong Chul KimSeung Hee YangTammy KimDong Ki KimChun Soo LimGeum-Sook HwangJung Pyo Lee
Published in: Kidney research and clinical practice (2023)
Myo-inositol can be used as an additive biomarker of ESRD progression in DKD.
Keyphrases
  • magnetic resonance
  • type diabetes
  • mass spectrometry
  • cancer therapy
  • contrast enhanced
  • magnetic resonance imaging
  • computed tomography